Our cutting-edge products lead the way in neuroendovascular therapies.
Ischemic Stroke and Carotid Artery Disease
Access Product Solutions
MicroVention's 25th Anniversary History of Innovations
Sep 21, 2023
MicroVention Enters Transradial Access Therapy; Receives FDA Clearance of SOFIA™ EX 5F 115cm Intracranial Support Catheter
MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the SOFIA™ EX 5F 115 cm Intracranial Support Catheter (Soft TOrqueable catheter For Intracranial Access) has received FDA 510(k) clearance on September 15, 2023, for transradial access in addition to transfemoral access.
Jul 31, 2023
MicroVention Announces 5-Year Clinical Trial Data and Size Additions for its WEB Aneurysm Embolization System; WEB is Most Well-Studied Intrasaccular Device Available Today
MicroVention’s WEB System is the World Leader and Only PMA-Approved Intrasaccular Flow Disruptor; Advances Treatment of Wide-Neck Bifurcation Aneurysms with ONE Device